Holen Sie sich die Stockscreener-App
12.01
1.56%
-0.19
Schlusskurs vom Vortag:
$12.20
Offen:
$12.48
24-Stunden-Volumen:
567.03K
Relative Volume:
1.16
Marktkapitalisierung:
$191.45M
Einnahmen:
$13.11M
Nettoeinkommen (Verlust:
$-124.02M
KGV:
-0.8422
EPS:
-14.261
Netto-Cashflow:
$-107.25M
1W Leistung:
+12.77%
1M Leistung:
-15.78%
6M Leistung:
-34.05%
1J Leistung:
-65.01%
1-Tages-Spanne:
$11.89
$12.87
1-Wochen-Bereich:
$10.41
$12.87
52-Wochen-Spanne:
$10.03
$69.97
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Firmenname
Tonix Pharmaceuticals Holding Corp
Sektor
Branche
Telefon
212-980-9155
Adresse
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NY
Compare TNXP vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
12.01 | 191.45M | 13.11M | -124.02M | -107.25M | -14.26 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-04-18 | Eingeleitet | Noble Capital Markets | Outperform |
| 2019-04-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2017-08-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2016-09-07 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-02-17 | Bestätigt | Oppenheimer | Outperform |
| 2015-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-12 | Eingeleitet | Oppenheimer | Outperform |
| 2015-02-17 | Bestätigt | ROTH Capital | Buy |
| 2014-09-29 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten
Millennium Management LLC Increases Stake in Tonix Pharmaceutica - GuruFocus
Why TNXP Stock Is Suddenly Back On Retail Radar - Stocktwits
Tonix Pharmaceuticals Holding Corp (TNXP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TNXP Slips After Hours On Slower Than Expected Launch For Fibromyalgia Drug - Stocktwits
Tonix Pharmaceuticals Holding Corp - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tonix Pharmaceuticals (TNXP) Investor presentation Summary - Quartr
Tonix Pharmaceuticals Holding Corp (TNXP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Institutional Confidence - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tonix Pharmaceuticals Holding Corp at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
Millennium group reports 890,366 shares (5.6%) in Tonix (TNXP) - Stock Titan
Tonix Pharmaceuticals director Taylor buys $14,928 in stock By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals director Taylor buys $14,928 in stock - Investing.com
Insider Buying: Carolyn Taylor Acquires Shares of Tonix Pharmace - GuruFocus
Director Carolyn Taylor buys Tonix Pharmaceuticals (TNXP) shares in open market - Stock Titan
Tonix Pharmaceuticals Holding Corp (TNXP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tonix Pharmaceuticals Holding (TNXP) price target decreased by 15.76% to 55.42 - MSN
We're Keeping An Eye On Tonix Pharmaceuticals Holding's (NASDAQ:TNXP) Cash Burn Rate - Yahoo Finance
Tonix Pharmaceuticals Holding Corp (TNXP) Stock Price, Quote, News & History - Benzinga
Tonix Pharmaceuticals Holding Corp. Trade Ideas — TRADEGATE:TPM0 - TradingView
Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026 - marketscreener.com
(TNXP) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tonix CEO Seth Lederman buys $58,949 in company stock By Investing.com - Investing.com Canada
Insider Buying: Richard Stillwell Acquires Shares of Tonix Pharm - GuruFocus
Tonix Pharmaceuticals director Stillwell buys $58,250 in shares By Investing.com - Investing.com Canada
Tonix CEO Seth Lederman buys $58,949 in company stock - Investing.com UK
Tonix Pharmaceuticals director Stillwell buys $58,250 in shares - Investing.com
[Form 4] Tonix Pharmaceuticals Holding Corp. Insider Trading Activity - Stock Titan
Tonix (NASDAQ: TNXP) CEO Lederman acquires 5,000 shares in open-market buy - Stock Titan
Tonix Pharmaceuticals (TNXP) Expands Tonmya Coverage to 17 Milli - GuruFocus
TNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - Stocktwits
Blue Owl Capital (OBDC) Regains Ground: Modest Gain Signals Stability Near Key LevelsBearish Sentiment - newsline.com
symbol__ Stock Quote Price and Forecast - CNN
Tonix Pharmaceuticals Expands TONMYA® Fibromyalgia Coverage to 52 Million Lives with Second Major GPO Agreement - Minichart
Tonix Pharmaceuticals stock gains on expanded TONMYA coverage By Investing.com - Investing.com Nigeria
Tonix Pharmaceuticals stock gains on expanded TONMYA coverage - Investing.com
Tonix expands commercial coverage for fibromyalgia drug TONMYA - Investing.com UK
Tonix expands commercial coverage for fibromyalgia drug TONMYA By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals secures GPO coverage for TONMYA, expanding commercial access to ~52M U.S. lives - TradingView
TONMYA coverage reaches 52M U.S. commercial lives under GPO deals (TNXP) - Stock Titan
Tonix Pharmaceuticals Secures Second Commercial Payer - GlobeNewswire
Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):